Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Jardiance phase 3 exercise ability studies in chronic heart failure fail to meet primary endpoint

pharmaceutical-business-reviewDecember 20, 2019

Tag: Jardiance , chronic heart failure , boehringer , Lilly , EMPERIAL

PharmaSources Customer Service